Action Required: Password Reset on Next Login

As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.

To reset your password, please visit the Reset Password page.

We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Amarna Therapeutics B.V.

Headquarters: Leiden, Netherlands
Year Founded: 2008
Status: Private

BioCentury | Apr 23, 2024
Management Tracks

Bill Meury named CEO of Anthos

Plus: Fujimoto to lead Takeda-Astellas-Sumitomo’s JV, and updates from Sofinnova Partners, SystImmune, Amarna and Cytonus
BioCentury | Jun 8, 2023
Management Tracks

New CFO, commercial officer at Pulmocide

Plus: Helmling named CBO at eTheRNA, and updates from EpimAb, Ring, Amarna, XNK and more
BioCentury | Sep 8, 2020
Management Tracks

Black Diamond names Humphrey CMO; plus Edmondson to lead chemistry at Nimbus, Recce, Amarna and more

Rachel Humphrey has joined Black Diamond Therapeutics Inc. (NASDAQ:BDTX) as CMO. Karsten Witt, who has been SVP of clinical development and acting CMO since May 2019, will become SVP of non-clinical
BioCentury | Jan 25, 2016
Emerging Company Profile

Mining ALS possibilities

Patient-founded Treeway seeks to turn ALS into a manageable, chronic condition
BioCentury | Aug 3, 2015
Company News

Amarna Therapeutics, CBMed deal

Items per page:
1 - 6 of 6
Username